These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26100005)

  • 1. Does Cox analysis of a randomized survival study yield a causal treatment effect?
    Aalen OO; Cook RJ; Røysland K
    Lifetime Data Anal; 2015 Oct; 21(4):579-93. PubMed ID: 26100005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doubly robust estimation of attributable fractions in survival analysis.
    Sjölander A; Vansteelandt S
    Stat Methods Med Res; 2017 Apr; 26(2):948-969. PubMed ID: 25519888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal inference in survival analysis using pseudo-observations.
    Andersen PK; Syriopoulou E; Parner ET
    Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.
    Axelrod R; Nevo D
    Biometrics; 2023 Sep; 79(3):2743-2756. PubMed ID: 36385393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating prognostic factors into causal estimators: a comparison of methods for randomised controlled trials with a time-to-event outcome.
    Hampson LV; Metcalfe C
    Stat Med; 2012 Nov; 31(26):3073-88. PubMed ID: 22714785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating treatment effect in a proportional hazards model in randomized clinical trials with all-or-nothing compliance.
    Li S; Gray RJ
    Biometrics; 2016 Sep; 72(3):742-50. PubMed ID: 26799700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust versus consistent variance estimators in marginal structural Cox models.
    Enders D; Engel S; Linder R; Pigeot I
    Stat Med; 2018 Oct; 37(24):3455-3470. PubMed ID: 29888510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instrumental variable estimation of the causal hazard ratio.
    Wang L; Tchetgen Tchetgen E; Martinussen T; Vansteelandt S
    Biometrics; 2023 Jun; 79(2):539-550. PubMed ID: 36377509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretable inference on the mixed effect model with the Box-Cox transformation.
    Maruo K; Yamaguchi Y; Noma H; Gosho M
    Stat Med; 2017 Jul; 36(15):2420-2434. PubMed ID: 28294388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of time to event outcomes in randomized controlled trials by generalized additive models.
    Argyropoulos C; Unruh ML
    PLoS One; 2015; 10(4):e0123784. PubMed ID: 25906075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis.
    Stitelman OM; De Gruttola V; van der Laan MJ
    Int J Biostat; 2012 Sep; 8(1):. PubMed ID: 22992289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust inference in discrete hazard models for randomized clinical trials.
    Nguyen VQ; Gillen DL
    Lifetime Data Anal; 2012 Oct; 18(4):446-69. PubMed ID: 22810273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of a decreasing hazard of patients with acute coronary syndrome.
    van Geloven N; Martin I; Damman P; de Winter RJ; Tijssen JG; Lopuhaä HP
    Stat Med; 2013 Mar; 32(7):1223-38. PubMed ID: 22829475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How serious is bias in effect estimation in randomised trials with survival data given risk heterogeneity and informative censoring?
    McNamee R
    Stat Med; 2017 Sep; 36(21):3315-3333. PubMed ID: 28621000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.